SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors debate the sustainability of the AI capex cycle, with sentiment currently torn between excitement over fresh price target upgrades and caution following reports of potential excess compute capacity at major hyperscalers. The community is actively tracking support levels amid high volatility, as traders watch for a breakout or consolidation while navigating a holiday-shortened trading week.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors debate the impact of pre-planned insider stock sales against the backdrop of significant bullish sentiment, driven by high short interest and anticipation of upcoming global growth catalysts. The community remains focused on the company's platform potential and the ongoing struggle between retail longs and short sellers amid broader biotech sector momentum.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors weigh strong demand for AI-optimized servers against significant stock price volatility and recent insider activity. The market remains deeply focused on the company's enterprise-level backlog and government contract wins, while simultaneously debating its valuation and long-term sustainability compared to other AI infrastructure players.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently in the spotlight following the announcement of a massive 20-year, 401 MW data center lease with AI lab Anthropic, expected to generate significant long-term contracted revenue. While the stock has seen high volatility and community frustration regarding management's communication and recent price dips, investors remain focused on the company's strategic pivot toward wholly-owned AI infrastructure and its expanding contracted backlog.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is facing significant volatility as investors weigh robust demand and raised guidance against management's warnings of persistent supply chain constraints impacting margins. The community is actively debating whether this pullback represents an attractive long-term entry point into a foundational AI infrastructure play or if broader technical weakness will lead to further consolidation.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trading in a consolidation phase as investors navigate the pending $35-per-share acquisition by Hapag-Lloyd while monitoring developments around a competing Israeli-led buyout proposal. The community remains focused on the significant arbitrage spread, the potential for a bidding war, and upcoming dividend payouts, despite concerns regarding regulatory hurdles and regional geopolitical tensions.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is seeing significant market activity as investors weigh its AI-driven insurance model and recent expansion into FSD auto insurance against heightened volatility and recent insider selling. The community is actively debating the stock's long-term growth potential and turnaround narrative ahead of its upcoming earnings report, with many focusing on whether recent technical pullbacks represent a buying opportunity or a deeper shift in sentiment.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is seeing significant market movement as investors react to a quarterly earnings report that featured a revenue beat, raised full-year guidance, and a new four-for-one stock split announcement. The community is actively debating whether the double-digit pullback represents a healthy valuation reset after a sharp rally or if the stock remains overvalued compared to its cybersecurity peers.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is experiencing heightened interest as market narratives shift toward the structural necessity of data protection and cyber resilience in the wake of expanding Agentic AI workloads. Community discussion is heavily focused on the stock's transition from a legacy software category to an AI-era growth leader, with many noting a steady, quiet accumulation by institutional investors who view the platform as an essential layer in the modern digital infrastructure.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is currently a focus for traders navigating a rotating market as the company pushes a 'Back to Starbucks' turnaround strategy alongside cost-cutting measures and loyalty program shifts. Community sentiment is deeply split, with bulls eyeing long-term value and operational momentum, while bears highlight risks from inflation, weakening consumer spending, and the company's complex international footprint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA PR Newswire NEW YORK, May 28, 2026 NEW YORK, May 28, 2026...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA PR Newswire NEW YORK, May 14, 2026 NEW YORK, May 14, 2026...

Entrada Therapeutics Clinical Trial Data Sparks Brutal Stock Selloff - Here's Why

Entrada Therapeutics stock plunged after the Duchenne trial data missed investor expectations despite positive functional improvement signals.read more...

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) delivered earnings and revenue surprises of +10.59% and -86.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Entrada Therapeutics (TRDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Entrada Therapeutics (NASDAQ:TRDA) Insider Sells $398,708.73 in Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) insider Natarajan Sethuraman sold 25,907 shares of the company's stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $15.39, for a total value of $398,708.73. Following the transaction, the insider...

Entrada Therapeutics (NASDAQ:TRDA) COO Nathan Dowden Sells 15,000 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 15,000 shares of the firm's stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $15.33, for a total transaction of $229,950.00. Following the transaction, the chief operating...

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of -30.74% and -1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Entrada Therapeutics (NASDAQ:TRDA) Trading 7.6% Higher - Should You Buy?

Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 7.6% - What's Next...

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Entrada Therapeutics Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$7.71
Prev Close	$7.72
Open	$7.59
Dividend Yield	0.00%
50-Day Moving Average	$8.35
Beta	1.55
Avg. Volume	300,047.30
PE Ratio	-1.93

52-Week High	$16.45
52-Week Low	$4.93
Market Capitalization	$299.7M
EPS (Annual)	-$3.47
Price to Book	1.11
Revenue Per Employee	$167,243.42

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRDAEntrada Therapeutics Inc

Latest TRDA News